Skip to main content
Equibles
IKT logo

IKT · Inhibikase Therapeutics, Inc. · Proposed Sales

Track IKT — free

Use IKT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IKT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.53 -0.10 (-6.13%) At close · Nov 12 Q2 2024 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$214.61M
Shares
140.27M
Volume · Nov 12 728.31K Avg daily vol (3M) 566.38K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1750149 CUSIP 45719W205 13F (30d) 48 filings 45 filers Visit website Investor relations